Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-030084
Filing Date
2017-05-04
Accepted
2017-05-04 17:31:08
Documents
2
Period of Report
2017-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5219
2 POA DOCUMENT poa.txt EX-24.3_721421 3284
  Complete submission text file 0001209191-17-030084.txt   9896
Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38085 | Film No.: 17815383

Mailing Address 205 EAST 42ND STREET SUITE 15-048 NEW YORK NY 10017
Business Address 205 EAST 42ND STREET SUITE 15-048 NEW YORK NY 10017 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations